MX2017002979A - Composiciones farmaceuticas de ofloxacino y ornidazol. - Google Patents

Composiciones farmaceuticas de ofloxacino y ornidazol.

Info

Publication number
MX2017002979A
MX2017002979A MX2017002979A MX2017002979A MX2017002979A MX 2017002979 A MX2017002979 A MX 2017002979A MX 2017002979 A MX2017002979 A MX 2017002979A MX 2017002979 A MX2017002979 A MX 2017002979A MX 2017002979 A MX2017002979 A MX 2017002979A
Authority
MX
Mexico
Prior art keywords
ornidazole
ofloxacin
pharmaceutical compositions
combination
preparing
Prior art date
Application number
MX2017002979A
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Podile Khadgapathi
Reddy Pothyreddy Venkateswar
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Priority to MX2017002979A priority Critical patent/MX2017002979A/es
Publication of MX2017002979A publication Critical patent/MX2017002979A/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se relaciona con la composición farmacéutica que contiene la combinación de ofloxacino y ornidazol. Particularmente, se relaciona con las composiciones orales sólidas que contienen la combinación de ofloxacino y ornidazol y el proceso para prepararlas.
MX2017002979A 2017-03-07 2017-03-07 Composiciones farmaceuticas de ofloxacino y ornidazol. MX2017002979A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2017002979A MX2017002979A (es) 2017-03-07 2017-03-07 Composiciones farmaceuticas de ofloxacino y ornidazol.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017002979A MX2017002979A (es) 2017-03-07 2017-03-07 Composiciones farmaceuticas de ofloxacino y ornidazol.

Publications (1)

Publication Number Publication Date
MX2017002979A true MX2017002979A (es) 2019-03-28

Family

ID=66592106

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002979A MX2017002979A (es) 2017-03-07 2017-03-07 Composiciones farmaceuticas de ofloxacino y ornidazol.

Country Status (1)

Country Link
MX (1) MX2017002979A (es)

Similar Documents

Publication Publication Date Title
PH12020550843A1 (en) Spray-dried 3-fucosyllactose
PH12018502516B1 (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
SA519401180B1 (ar) مركبات بيروليزين بها استبدال واستخداماتها
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
MX2019015744A (es) Composiciones farmaceuticas.
TN2017000524A1 (en) New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
JO3675B1 (ar) مشتقات هيدروكسي إستر جديدة،عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
EP4327880A3 (en) Solid state form of ribociclib succinate
MX2018012085A (es) Compuestos agonistas de gpr119 y metodo para tratar enfermedades y afecciones mediado a traves de gpr119.
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
PH12020550703A1 (en) Sulfonamide compounds and use thereof
PH12020550125A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
PH12020550133A1 (en) Crystal forms of immunomodulators
PH12018500852A1 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
IN2014CH00840A (es)
PH12018502246A1 (en) Substituted fused pyrimidinone compounds
IN2014MU00626A (es)
ZA202005083B (en) Solid forms of fasoracetam
MX2018015269A (es) Derivados de tailanstatina a, metodos de tratamiento y metodos de sintesis de los mismos.
MX2017002979A (es) Composiciones farmaceuticas de ofloxacino y ornidazol.
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
MX2017015505A (es) Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma.